Isolation and characterization of a novel human bladder cancer cell line: BK10.

Journal Article (Journal Article)

Molecular studies of bladder carcinomas have aided in determining causative genetic events and the prognosis of cancers endowed with certain abnormalities. In vitro bladder cancer characterization of key cytogenetic alterations is useful for study of molecular changes that may promote oncogenic events. In our laboratory, a novel human bladder cancer cell line, BK10, has been established in vitro and passaged for more than 20 mo. This new bladder cancer cell line (BK10) was derived from bladder tissue containing grade III-IV/IV transitional cell carcinoma. Bladder cancer tissue was obtained at the time of radical cystoprostatectomy extirpation. Cell cultures derived from this surgical sample exhibited an epithelial morphology and expressed epithelial cytokeratins. Immunostains of BK10 were negative for prostate specific antigen (PSA), fibronectin, smooth muscle actin alpha, and desmin. Karyotypic analysis revealed an aneuploid chromosomal content <4n> with many numerical and structural abnormalities previously linked to bladder oncogenesis. Translocations occurred in chromosomes 1, 2, 3, 4, 5, 6, 7, 8, 9, 11, 13, 14, 15, 16, 17, 19, 20, 21, 22, X and Y. G-banding analysis revealed rearrangements involving chromosomes 9q and 17p, and the location of the ab11 oncogene and the p53 gene, respectively. The availability of this bladder cancer cell line will provide a useful tool for the further study of bladder carcinoma oncogenesis and gene therapy.

Full Text

Duke Authors

Cited Authors

  • Roberson, KM; Yancey, DR; Padilla-Nash, H; Edwards, DW; Nash, W; Jacobs, S; Padilla, GM; Larchian, WA; Robertson, CN

Published Date

  • July 1998

Published In

Volume / Issue

  • 34 / 7

Start / End Page

  • 537 - 544

PubMed ID

  • 9719413

International Standard Serial Number (ISSN)

  • 1071-2690

Digital Object Identifier (DOI)

  • 10.1007/s11626-998-0113-y


  • eng

Conference Location

  • Germany